Behuliak Michal, Vavřínová Anna, Bencze Michal, Polgárová Kamila, Ergang Peter, Kuneš Jaroslav, Vaněčková Ivana, Zicha Josef
aInstitute of Physiology, Czech Academy of Sciences bDepartment of Physiology, Faculty of Sciences, Charles University, Prague, Czech Republic.
J Hypertens. 2015 Dec;33(12):2443-54. doi: 10.1097/HJH.0000000000000746.
Altered calcium sensitization (mediated by RhoA/Rho-kinase pathway) and enhanced calcium entry through L-type voltage-dependent calcium channels (L-VDCCs) participate in blood pressure (BP) maintenance of adult spontaneously hypertensive rats (SHRs). This study aimed to evaluate ontogenetic changes of these two pathways in BP control of SHR and Wistar-Kyoto (WKY) aged 3, 5, 7, 13, 26 and 42 weeks.
BP response to acute administration of Rho-kinase inhibitor fasudil or L-VDCC blocker nifedipine and the expression of particular components of RhoA/Rho-kinase pathway were determined in young and adult animals.
Fasudil-induced BP reduction was attenuated in young SHR compared with WKY, but was enhanced in adult SHR. In contrast, BP response to nifedipine was similar in 3-week-old SHR and WKY and it was augmented with age in SHR but not in WKY. Consequently, the ratio between fasudil-induced and nifedipine-induced BP changes was lower in all age groups of SHR compared with WKY. Fasudil effects on contractility of isolated arteries were attenuated in young but not in adult SHR. mRNA expression of selected Rho-GEFs (Arhgef1, Arhgef11 and Arhgef12) was decreased only in adult SHR, whereas p63RhoGEF and CPI-17 expression was reduced in both age groups of SHR. Active RhoA and phosphorylated CPI-17 were increased in adult but not in young SHR.
The importance of RhoA/Rho-kinase pathway for BP/vascular tone control is attenuated in SHR from prehypertensive stages. Enhanced RhoA activation and/or CPI-17 phosphorylation might be counteracted by reduced expression of upstream activators of Rho-kinase (Rho-GEFs) together with lower expression of CPI-17 (in downstream cascade of Rho-kinase).
钙敏化改变(由RhoA/ Rho激酶途径介导)以及通过L型电压依赖性钙通道(L-VDCCs)的钙内流增强参与成年自发性高血压大鼠(SHR)的血压(BP)维持。本研究旨在评估这两条途径在3、5、7、13、26和42周龄SHR和Wistar-Kyoto(WKY)大鼠血压控制中的个体发育变化。
测定了年轻和成年动物对急性给予Rho激酶抑制剂法舒地尔或L-VDCC阻滞剂硝苯地平的血压反应以及RhoA/ Rho激酶途径特定成分的表达。
与WKY相比,年轻SHR中法舒地尔诱导的血压降低减弱,但成年SHR中增强。相反,3周龄SHR和WKY对硝苯地平的血压反应相似,且SHR中随年龄增加而增强,而WKY中无此现象。因此,与WKY相比,SHR所有年龄组中法舒地尔诱导的和硝苯地平诱导的血压变化之比更低。法舒地尔对离体动脉收缩性的作用在年轻SHR中减弱,但在成年SHR中未减弱。所选Rho-GEFs(Arhgef1、Arhgef11和Arhgef12)的mRNA表达仅在成年SHR中降低,而p63RhoGEF和CPI-17表达在SHR的两个年龄组中均降低。活性RhoA和磷酸化CPI-17在成年SHR中增加,但在年轻SHR中未增加。
在高血压前期阶段的SHR中,RhoA/ Rho激酶途径对血压/血管张力控制的重要性减弱。Rho激酶上游激活剂(Rho-GEFs)表达降低以及CPI-17(在Rho激酶下游级联反应中)表达降低可能抵消了RhoA激活增强和/或CPI-17磷酸化增加的作用。